A multicenter study of recombinant factor VIII (recombinate) : safety, efficacy, and inhibitor risk in previously untreated patients with hemophilia A. The Recombinate Study Group

1 Citations

Journal

  • Blood

    Blood 83 2428-2435, 1994

Citations (1)*help

See more

Details 詳細情報について

  • CRID
    1570854176058222976
  • NII Article ID
    10026116734
  • Data Source
    • CiNii Articles

Report a problem

Back to top